Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

600222 Henan Taloph Pharmaceutical Stock

Watchlist
8.070
+0.190+2.41%
Closed 11/28 15:00 CCT
High
8.220
Open
7.610
Turnover
853.34M
Low
7.610
Pre Close
7.880
Volume
1.06Mlot
Market Cap
4.63B
P/E(TTM)
Loss
52wk High
9.630
Shares
573.89M
P/E(Static)
807.00
52wk Low
4.640
Float Cap
4.63B
Bid/Ask %
-3.74%
Historical High
17.944
Shs Float
573.89M
Volume Ratio
0.90
Historical Low
1.675
Dividend TTM
0.01
Div Yield TTM
--
P/B
2.96
Dividend LFY
0.01%
Div Yield LFY
--
Turnover Ratio
18.50%
Amplitude
7.74%
Avg Price
8.037
Lot Size
100
Float Cap
4.63B
Bid/Ask %
-3.74%
Historical High
17.944
Shs Float
573.89M
Volume Ratio
0.90
Historical Low
1.675
Dividend TTM
0.01
Limit Up
8.670
P/B
2.96
Dividend LFY
0.01%
Limit Down
7.090
Turnover Ratio
18.50%
Amplitude
7.74%
Avg Price
8.037
Lot Size
100
Ask
515.06Klot
Bid
560.94Klot
Price Forecast

No Data

News

Comment

Sign in to post a comment

    No comment yet

    Company Overview More
    The company is approved by Henan Economic system Reform Commission (1998) No. 38, with Zhengzhou Zhongsheng Industrial Group Co., Ltd. as the main sponsor. Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhulin Xianzhu washing products Co., Ltd., Zhengzhou Zhulin Refractory Co., Ltd., Gongyi Zhulin Xinhua Packaging material Factory and other five enterprises jointly initiated and established the joint stock co., Ltd. With the approval of document No. 98 issued by CSRC [1999], the company issued 35 million public shares on August 13, 1999, with a total share capital of 136.14524 million yuan. The company's main business is drug manufacturing and drug R & D services, including pharmaceutical preparations, traditional Chinese medicine slices, drug R & D services and the circulation of pharmaceutical materials. The company's pharmaceutical preparation business is mainly oral preparation of traditional Chinese medicine, covering respiratory system, cardio-cerebrovascular, digestive system, nervous system and gynecological diseases. the main products include Shuanghuanglian oral liquid series, Shuanghuanglian mixture, Salvia miltiorrhiza oral liquid, Xiaoer Qingre Zhike oral liquid, children compound chicken inner gold chewable tablets, Huperzine A tablets and so on. Among them, Shuanghuanglian oral liquid (concentrated), Shuanghuanglian oral liquid (children's type), Shuanghuanglian mixture and children's compound chicken inner gold chewing tablets are the company's exclusive products. Enterprise honor: the all-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce awarded the company the honor of "Anti-epidemic Charity and Love", Henan High-tech Enterprises, "National High-tech industrialization demonstration Project", "excellent Enterprises in Zhengzhou" and so on.
    CEO: --
    Market: --
    Listing Date: 11/05/1999
    Hot List
    TradeSearchNews
    SymbolLatest price%Chg

    Loading...

    Watchlist